METHOD AND RESULTS 3. IN VIVO

1
METHOD AND RESULTS 3. IN VIVO DISCUSSION Christoph Fusch, Dpt. Of Pediatrics, McMaster University, Hamilton, Ontario, L8S 4K1, Canada, Phone: +1 (905) 521 2100 ext 75721, E-mail: [email protected] METHOD 1, 2: FABRICATION OF SOU/ LAD AND IN VITRO GAS EXCHANGE EXPERIMENTAL SETUP SOU Body: • Polydimethylsiloxane (PDMS) Vascular network of micro channels Low volume of 0.14mL Collect blood samples pre- and post SOU for gas analysis flow rate: 0.5 – 4 mL/min Gas Permeable Membrane: • Polycarbonate (PC),normal PDMS, or porous PDMS Surface area of 14.08cm 2 “Lung Assist Device for term and preterm newborns with respiratory failure- Artificial Placenta A. Manan 1 , N. Rochow 2 , W. Wu 3 , G. Fusch 2 ,S. Monkman 2 , PR. Selvaganapthy 3 , C. Fusch 1,2 1 Dpt. of Biomedical Engineering, 2 Div. of Neonatology, Dpt. of Pediatric, 3 Department of Mechanical Engineering, McMaster University INTRODUCTION Respiratory failure still accounts for 5% of neonatal deaths. Mechanical ventilation is associated with long term complications. Based on the natural in utero placenta, we propose a pump less lung assist device (LAD) with low priming volume, low resistance, and high gas exchange. OBJECTIVE ACKNOWLEDGMENT CHRP Funding Received Provisional US Patent is filed, No. 61526288 Rochow et al, 2013. Int J Artif Organs Wen-I-W et al, 2013. Lab on Chip C. Fusch holds the Hamilton Health Sciences Foundation Jack Sinclair Chair in Neonatology at McMaster University RESULTS 1: IN VITRO GAS EXCHANGE OF SOU Postnatal: artificial placenta Porous PDMS was superior to PC, normal PDMS membranes by demonstrating a1.6x- 2.6x higher O 2 and 1.2x- 2.4x higher CO 2 exchange rate. RESULT 2: IN VITRO GAS EXCHANGE OF LAD 1. In vitro: Optimize SOU, by testing gas exchange rates of different membrane. 2. In vitro: Evaluate gas exchange rates of LAD. 3. In vivo: Assess feasibility of LAD in hypoxic piglet model. 5 10 15 20 30 40 0 0.0005 0.001 0.0015 0.002 0.0025 0.003 O2 Transfer per cm2 Flowrate (mL/min) O2 Transfer (mL/ min/cm2) 5 10 15 20 30 40 0 0.002 0.004 0.006 0.008 0.01 0.012 0.014 0.016 0.018 CO2 Transfer per cm2 Flowrate (mL/min) CO2 Transfer (mL/min/cm2) 5 10 15 20 30 40 0 10 20 30 40 50 60 Resistance of bundle Flow Rate (mL/min) Resistance (mmHg) 0 10 20 30 40 50 60 0 50 100 150 200 250 Flow rate vs. Heart Rate Flow rate (mLmin) Heart Rate 0 10 20 30 40 50 60 0 20 40 60 80 100 120 Flowrate vs. Blood Pressure Flow rate (mL/min) Blood Pressure Achieved a maximum flow rate of 57mL/minute No correlation is observed between flow rate and heart rate/ blood pressure, indicating that no additional stress is imposed on piglet by the LAD. T=2 sec T=7 sec T=18 sec Bundle can successfully support 10% neonatal lung function. 20-30% of CO 2 is successfully released, and with increasing flow rate results in improved CO 2 removal. Single Oxygenator Unit Lung Assist Device Newborn piglet 3-4 hours old Successfully constructed a low volume LAD. PDMS membranes was most effective for O 2 and CO 2 transfer. In vitro experiments indicate that the LAD can potentially provide support equivalent to 10% of neonatal lung function. In vivo experiments indicate that flow rates through device are tolerated by the cardiovascular system. Future work: Assess gas exchange performance of LAD in a hypoxic piglet model, improve biocompatibility, and develop special catheters to improve cannulation time. membrane PDMS body channel Porous PDMS have a 2x lower resistance than PC and 1.3x lower resistance than normal PDMS membrane.

description

T=2 sec. T=7 sec. T=18 sec. “Lung Assist Device for term and preterm newborns with respiratory failure- Artificial Placenta ” Manan 1 , N. Rochow 2 , W. Wu 3 , G. Fusch 2 ,S. Monkman 2 , PR. Selvaganapthy 3 , C. Fusch 1,2 - PowerPoint PPT Presentation

Transcript of METHOD AND RESULTS 3. IN VIVO

Page 1: METHOD AND RESULTS 3. IN VIVO

METHOD AND RESULTS 3. IN VIVO

DISCUSSION

Christoph Fusch, Dpt. Of Pediatrics, McMaster University, Hamilton, Ontario, L8S 4K1, Canada, Phone: +1 (905) 521 2100 ext 75721, E-mail: [email protected]

METHOD 1, 2: FABRICATION OF SOU/ LAD AND IN VITRO GAS EXCHANGE EXPERIMENTAL

SETUPSOU Body: • Polydimethylsiloxane (PDMS)• Vascular network of micro

channels• Low volume of 0.14mL

• Collect blood samples pre- and post SOU for gas analysis flow rate: 0.5 – 4 mL/min

Gas Permeable Membrane: • Polycarbonate (PC),normal

PDMS, or porous PDMS• Surface area of 14.08cm2

“Lung Assist Device for term and preterm newborns with respiratory failure- Artificial Placenta ”

A. Manan1, N. Rochow2, W. Wu3, G. Fusch2,S. Monkman2, PR. Selvaganapthy3, C. Fusch1,2

1Dpt. of Biomedical Engineering, 2Div. of Neonatology, Dpt. of Pediatric, 3Department of Mechanical Engineering, McMaster University

INTRODUCTION• Respiratory failure still accounts for 5% of neonatal deaths.

Mechanical ventilation is associated with long term complications. Based on the natural in utero placenta, we propose a pump less lung assist device (LAD) with low priming volume, low resistance, and high gas exchange.

OBJECTIVE

ACKNOWLEDGMENT

• CHRP Funding Received• Provisional US Patent is filed, No. 61526288• Rochow et al, 2013. Int J Artif Organs• Wen-I-W et al, 2013. Lab on Chip• C. Fusch holds the Hamilton Health Sciences Foundation

Jack Sinclair Chair in Neonatology at McMaster University

RESULTS 1: IN VITRO GAS EXCHANGE OF SOU

Postnatal: artificial placenta

• Porous PDMS was superior to PC, normal PDMS membranes by demonstrating a1.6x- 2.6x higher O2 and 1.2x- 2.4x higher CO2 exchange rate.

RESULT 2: IN VITRO GAS EXCHANGE OF LAD

• 1. In vitro: Optimize SOU, by testing gas exchange rates of

different membrane.2. In vitro: Evaluate gas exchange rates of LAD.3. In vivo: Assess feasibility of LAD in hypoxic piglet model.

5 10 15 20 30 400

0.0005

0.001

0.0015

0.002

0.0025

0.003O2 Transfer per cm2

Flowrate (mL/min)

O2

Tran

sfer

(mL/

min

/cm

2)

5 10 15 20 30 400

0.002

0.004

0.006

0.008

0.01

0.012

0.014

0.016

0.018CO2 Transfer per cm2

Flowrate (mL/min)

CO

2 Tr

ansf

er (m

L/m

in/c

m2)

5 10 15 20 30 400

10

20

30

40

50

60Resistance of bundle

Flow Rate (mL/min)

Res

ista

nce

(mm

Hg)

0 10 20 30 40 50 600

50

100

150

200

250Flow rate vs. Heart Rate

Flow rate (mLmin)

Hea

rt R

ate

0 10 20 30 40 50 600

20

40

60

80

100

120Flowrate vs. Blood Pressure

Flow rate (mL/min)

Blo

od P

ress

ure

• Achieved a maximum flow rate of 57mL/minute• No correlation is observed between flow rate and heart rate/

blood pressure, indicating that no additional stress is imposed on piglet by the LAD.

T=2 sec T=7 sec T=18 sec

• Bundle can successfully support 10% neonatal lung function.

• 20-30% of CO2 is successfully released, and with increasing flow rate results in improved CO2 removal.

Single Oxygenator Unit Lung Assist Device

Newborn piglet 3-4 hours old

• Successfully constructed a low volume LAD.• PDMS membranes was most effective for O2 and CO2

transfer.• In vitro experiments indicate that the LAD can potentially

provide support equivalent to 10% of neonatal lung function.• In vivo experiments indicate that flow rates through device

are tolerated by the cardiovascular system.• Future work: Assess gas exchange performance of LAD in

a hypoxic piglet model, improve biocompatibility, and develop special catheters to improve cannulation time.

membrane

PDMS body

channel

• Porous PDMS have a 2x lower resistance than PC and 1.3x lower resistance than normal PDMS membrane.